Andrew Rosivach
Wolfe Research | Real Estate
Andrew Rosivach is an analyst from Wolfe Research specializing in the Real Estate sector. Ranked #1376 out of 4363 analysts, they have issued 10 stock ratings with a success rate of 90.38% and an average return of 11.40%.
With 10 ratings to date, Andrew Rosivach is beginning to establish credibility in the Real Estate sector. They have achieved a success rate of 90.38% and an average return of 11.40%, highlighting promising potential as their track record develops further.
Recent Ratings Analysis
REXR
HoldOct 20, 2025
Target
$0.00
Current
$44.26
Performance
0.00%
Andrew Rosivach rated REXR as Peer Perform on Oct 20, 2025, setting a price target of null. The Hold stance appears justified, as shares hovered around 44.26 with a 0.00% move.
DLR
BuyOct 20, 2025
Target
$194.00
Current
$172.92
Performance
0.00%
On Oct 20, 2025, DLR was given a Outperform rating by Andrew Rosivach, with a target price of 194. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.
CCI
BuySep 22, 2025
Target
$114.00
Current
$98.87
Performance
4.87%
CCI received a Outperform rating from Andrew Rosivach on Sep 22, 2025, aiming for 114. Price action was muted, as shares hovered around 98.87 despite the bullish outlook.
AIV
BuyAug 04, 2025
Target
$10.00
Current
$5.65
Performance
-33.29%
On Aug 04, 2025, Andrew Rosivach published a Outperform outlook on AIV, with a target of 10. Market action contradicted the Buy thesis, as shares slipped to 5.65.
BNL
BuyJul 28, 2025
Target
$19.00
Current
$18.83
Performance
19.40%
Andrew Rosivach on Jul 28, 2025 assigned BNL a Outperform rating, with a price target of 19. The Buy call aligned well with market performance, producing a gain of 19.40%.
O
HoldJul 15, 2025
Target
$0.00
Current
$60.64
Performance
7.02%
On Jul 15, 2025, Andrew Rosivach reaffirmed O with a Peer Perform rating, targeting null. Market strength beyond 60.64 went further than the conservative outlook suggested.
IIPR
HoldJul 02, 2025
Target
$0.00
Current
$54.64
Performance
-4.26%
IIPR was rated Peer Perform by Andrew Rosivach on Jul 02, 2025, with a price objective of null. Flat performance suggests the Hold view was reasonable.
PLD
HoldApr 21, 2025
Target
$0.00
Current
$127.18
Performance
28.95%
On Apr 21, 2025, Andrew Rosivach initiated coverage on PLD with a Peer Perform rating and target of null. The Hold stance underestimated the stock’s strength as it gained 28.95%.
CUZ
BuyApr 07, 2025
Target
$31.00
Current
$26.59
Performance
3.42%
Andrew Rosivach issued a Outperform recommendation for CUZ on Apr 07, 2025, price target set at 31. The target of 31 remains in play, though confirmation will depend on future moves.
IVT
HoldMar 20, 2025
Target
$0.00
Current
$28.22
Performance
-2.59%
On Mar 20, 2025, IVT was evaluated by Andrew Rosivach, who gave a Peer Perform rating and target of null. Hold sentiment was validated by subdued trading with no breakout beyond 28.22.
JLL
BuyNov 25, 2024
Target
$353.00
Current
$306.34
Performance
7.99%
Andrew Rosivach rated JLL as Outperform on Nov 25, 2024, setting a price target of 353. The call has proven timely, with shares rising 7.99% toward the price target of 353.
NMRK
HoldNov 25, 2024
Target
$0.00
Current
$18.60
Performance
19.85%
On Nov 25, 2024, NMRK was given a Peer Perform rating by Andrew Rosivach, with a target price of null. The stock rallied from 18.6 to 18.6 after the Hold rating, surprising to the upside.
GLPI
BuyAug 23, 2024
Target
$57.00
Current
$45.11
Performance
-11.10%
GLPI received a Outperform rating from Andrew Rosivach on Aug 23, 2024, aiming for 57. The rating hasn’t played out as hoped, with the stock trading 11.10% below expectations.
HPP
HoldAug 14, 2024
Target
$0.00
Current
$2.55
Performance
-44.08%
On Aug 14, 2024, Andrew Rosivach published a Peer Perform outlook on HPP, with a target of null. Weakness in the stock, now at 2.55, supported the conservative rating.
COLD
BuyJul 01, 2024
Target
$31.00
Current
$13.65
Performance
-46.78%
Andrew Rosivach on Jul 01, 2024 assigned COLD a Outperform rating, with a price target of 31. The call has struggled to gain traction, with shares losing 46.78%.